<DOC>
	<DOCNO>NCT00409708</DOCNO>
	<brief_summary>This study assess frequency chromosomal abnormality measure circulate lymphocyte treatment-naive child Attention Deficit Hyperactivity Disorder ( ADHD ) treat 3 month either extend release methylphenidate behavioral therapy .</brief_summary>
	<brief_title>Effects Methylphenidate Cellular Abnormalities Children With Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>This study determine whether administration extended-release methylphenidate treatment-na√Øve child Attention Deficit Hyperactivity Disorder ( ADHD ) affect frequency chromosomal abnormality .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Chromosome Aberrations</mesh_term>
	<mesh_term>Chromosome Disorders</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Children gender , 612 year old Written inform consent parent patient ( 7 ) Diagnosis ADHD Ageappropriate cognitive function All patient least one postbaseline cytogenetic assessment core study enter observation phase . History malignant neoplasm History seizure ( except childhood febrile seizure ) Hyperthyroidism Concurrent medical condition may interfere study Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder ,</keyword>
	<keyword>ADHD</keyword>
	<keyword>Cytogenetic abnormality ,</keyword>
	<keyword>extended-release methylphenidate ,</keyword>
</DOC>